Cart
sales@molnova.com
CCG-203971
CAS No. 1443437-74-8
CCG-203971( CCG-203971 | CCG 203971 )
Catalog No. M18020 CAS No. 1443437-74-8
CCG-203971 is an inhibitor of SRE activation in the prostate cancer cell line PC-3 (IC50: 6.4 μM), with 87% inhibition of SRE activation achieved at 100 μM.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 28 | In Stock |
|
| 10MG | 47 | In Stock |
|
| 25MG | 87 | In Stock |
|
| 50MG | 152 | In Stock |
|
| 100MG | 237 | In Stock |
|
| 500MG | 579 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameCCG-203971
-
NoteResearch use only, not for human use.
-
Brief DescriptionCCG-203971 is an inhibitor of SRE activation in the prostate cancer cell line PC-3 (IC50: 6.4 μM), with 87% inhibition of SRE activation achieved at 100 μM.
-
DescriptionCCG-203971 is an inhibitor of SRE activation in the prostate cancer cell line PC-3 (IC50: 6.4 μM), with 87% inhibition of SRE activation achieved at 100 μM. This compound also inhibits PC-3 cell migration (IC50: 4.2 μM), as determined by a scratch wound assay. CCG-203971 causes no cytotoxicity when evaluated by the WST-1 assay. It is well tolerated in normal mice up to doses of 100 mg/kg given intraperitoneally over five days.
-
In Vitro——
-
In Vivo——
-
SynonymsCCG-203971 | CCG 203971
-
PathwayCell Cycle/DNA Damage
-
TargetDNA/RNA Synthesis
-
Recptorothers
-
Research AreaCancer
-
Indication——
Chemical Information
-
CAS Number1443437-74-8
-
Formula Weight408.88
-
Molecular FormulaC23H21ClN2O3
-
Purity>98% (HPLC)
-
SolubilityDMSO : ≥ 155 mg/mL 379.08 mM; H2O : < 0.1 mg/mL
-
SMILESO=C(C1CN(C(C2=CC=CC(C3=CC=CO3)=C2)=O)CCC1)NC4=CC=C(Cl)C=C4
-
Chemical NameN-(4-chlorophenyl)-1-[3-(furan-2-yl)benzoyl]piperidine-3-carboxamide
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
DNA polymerase-IN-1
DNA polymerase-IN-1, a DNA polymerase inhibitor, exhibited antiproliferative activity against tumor cells with a half-inhibitory concentration (IC50) of 20.7 μM.
-
Homovanillic acid
Homovanillic acid is used as a reagent to detect oxidative enzymes, and is associated with dopamine levels in the brain.
-
APE1-IN-1
APE1-IN-1 is a potent inhibitor of purine/pyrimidine endonuclease 1 (APE1) that crosses the blood-brain barrier, exhibits potential antitumor activity, and enhances the cytotoxicity of the alkylating agent [methyl methanesulfonate] on cancer cells.
